Preferred Label : Selpercatinib Regimen;
NCIt synonyms : Retevmo Regimen;
NCIt related terms : Selpercatinib monotherapy;
NCIt definition : A regimen consisting of selpercatinib that may be used in the treatment of ampullary,
appendiceal, pancreatic, and small bowel adenocarcinomas, breast, biliary tract, cervical,
colorectal, and esophageal and esophagogastric junction cancers, hepatocellular carcinoma,
gastric, ovarian, fallopian tube, and primary peritoneal, vaginal, and occult primary
cancers, anaplastic carcinoma, follicular carcinoma, Hurthle cell carcinoma, medullary
carcinoma, non-small cell lung cancer (NSCLC), papillary carcinoma, salivary gland
tumors, extrapulmonary poorly differentiated neuroendocrine carcinoma/large or small
cell carcinoma/mixed neuroendocrine-non-neuroendocrine neoplasm, soft tissue sarcoma,
and certain histiocytic neoplasms, such as Langerhans cell histiocytosis, Erdheim-Chester
disease and Rosai-Dorfman disease.;
NCI Metathesaurus CUI : CL1792265;
Codes from synonyms : 18504;
Origin ID : C187233;
UMLS CUI : C5706974;
Est indiqué pour
- Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
